Table 2.

Concentrations (ng/g lipid) of PBDEs, DDE, HCB, and PCBs in colostrum (n = 290).^a

Compounds	< LOD (%)	LOD–LOQ (%)	> LOQ (%)	GM	Median	Minimum	Maximum
Σ7PBDEsb	NA	NA	NA	3.91	4.05	0.31	32.66
BDE-47	23.4	13.5	63.1	0.55	0.56	0.01	15.00
BDE-99	32.4	21.7	45.9	0.27	0.27	0.01	8.94
BDE-100	21.7	23.5	54.8	0.26	0.25	0.01	3.19
BDE-153	9.0	15.2	75.8	0.91	0.92	0.03	12.54
BDE-154	11.4	19.6	69.0	0.28	0.30	0.02	2.03
BDE-183	57.6	1.4	41.0	0.03	0.03	0.00	1.30
BDE-209	14.5	31.0	54.5	1.03	1.02	0.04	6.49
Σ7PCBsb	NA	NA	NA	107.50	118.60	9.17	894.45
PCB-28	34.8	16.2	49.0	1.60	1.71	0.01	16.81
PCB-52	39.0	23.1	37.9	1.66	2.13	0.00	82.51
PCB-101	77.6	17.6	4.8	1.24	1.26	0.03	22.76
PCB-118	11.7	17.2	71.1	5.68	5.76	0.38	96.68
PCB-138	0.7	1.3	98.0	23.14	26.03	1.28	222.99
PCB-153	1.0	0.7	98.3	34.50	37.15	1.24	369.01
PCB-180	1.7	0.7	97.6	30.34	32.96	1.45	266.27
HCB	2.8	1.7	95.5	26.21	28.75	0.34	251.63
DDE	0.3	0.0	99.7	104.94	98.57	2.16	8206.27
Abbreviations: LOD, number of samples below the limit of detection; LOD–LOQ, number of samples between the LOD and the LOQ; LOQ, number of samples above the limit of quantification; NA, not applicable. aValues are provided after multiple imputation of those which were below LOD or LOQ. bOnly those congeners detected in > 20% of the samples are shown and included in the final sum.